Literature DB >> 30191354

Construction strategies for developing expression vectors for recombinant monoclonal antibody production in CHO cells.

Yan-Mei Li1,2, Zheng-Wei Tian1,2, Dan-Hua Xu1,2, Xiao-Yin Wang1,2, Tian-Yun Wang3,4.   

Abstract

Recent years have seen the use of recombinant proteins in the treatment of different diseases. Among them, monoclonal antibodies (mAbs) are currently the fastest growing class of bio-therapeutic recombinant proteins. Chinese hamster ovary (CHO) cells are the most commonly used host cells for production of these recombinant mAbs. Expression vectors determine the expression level and quality of recombinant mAbs. Currently, few construction strategies for recombinant mAbs expression vectors in CHO cells have been developed, including monocistronic vector, multiple-promoter expression vector, and tricistronic vector mediated by internal ribosome entry site (IRES) or Furin-2A element. Among them, Furin-2A-mediated vector is an effective approach due to advantages of high "self-cleavage" efficiency, and equal expression of light and heavy chains from a single open reading frame. Here, we have reviewed the progress in development of different strategies for constructing recombinant mAb expression vectors in CHO cells and its potential advantages and disadvantages.

Entities:  

Keywords:  CHO cells; Furin-2A; IRES; Monoclonal antibodies; Recombinant proteins

Mesh:

Substances:

Year:  2018        PMID: 30191354     DOI: 10.1007/s11033-018-4351-0

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  40 in total

1.  2011 FDA drug approvals.

Authors:  Asher Mullard
Journal:  Nat Rev Drug Discov       Date:  2012-02-01       Impact factor: 84.694

Review 2.  Production of recombinant protein therapeutics in cultivated mammalian cells.

Authors:  Florian M Wurm
Journal:  Nat Biotechnol       Date:  2004-11       Impact factor: 54.908

Review 3.  Ribosomal Chamber Music: Toward an Understanding of IRES Mechanisms.

Authors:  Hiroshi Yamamoto; Anett Unbehaun; Christian M T Spahn
Journal:  Trends Biochem Sci       Date:  2017-07-03       Impact factor: 13.807

4.  Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells.

Authors:  Jake Chng; Tianhua Wang; Rui Nian; Ally Lau; Kong Meng Hoi; Steven C L Ho; Peter Gagnon; Xuezhi Bi; Yuansheng Yang
Journal:  MAbs       Date:  2015       Impact factor: 5.857

5.  An improved retroviral vector for assaying promoter activity. Analysis of promoter interference in pIP211 vector.

Authors:  K Nakajima; K Ikenaka; K Nakahira; N Morita; K Mikoshiba
Journal:  FEBS Lett       Date:  1993-01-04       Impact factor: 4.124

6.  Molecular analysis of successful cell line selection in transfected GS-NS0 myeloma cells.

Authors:  Louise M Barnes; Catherine M Bentley; Nicola Moy; Alan J Dickson
Journal:  Biotechnol Bioeng       Date:  2007-02-01       Impact factor: 4.530

7.  Vector fragmentation: characterizing vector integrity in transfected clones by Southern blotting.

Authors:  Say Kong Ng; Wenyu Lin; Rohit Sachdeva; Daniel I C Wang; Miranda G S Yap
Journal:  Biotechnol Prog       Date:  2010 Jan-Feb

8.  An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice.

Authors:  Zifei Pei; Liang Chu; Weiguo Zou; Zilai Zhang; Songbo Qiu; Rong Qi; Jinfa Gu; Cheng Qian; Xinyuan Liu
Journal:  Hepatology       Date:  2004-05       Impact factor: 17.425

9.  Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vector.

Authors:  Ziqing Liu; Olivia Chen; J Blake Joseph Wall; Michael Zheng; Yang Zhou; Li Wang; Haley Ruth Vaseghi; Li Qian; Jiandong Liu
Journal:  Sci Rep       Date:  2017-05-19       Impact factor: 4.379

10.  Evaluating the efficiency of CHEF and CMV promoter with IRES and Furin/2A linker sequences for monoclonal antibody expression in CHO cells.

Authors:  Saeedeh Ebadat; Samira Ahmadi; Maryam Ahmadi; Fatemeh Nematpour; Farzaneh Barkhordari; Reza Mahdian; Fatemeh Davami; Fereidoun Mahboudi
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

View more
  4 in total

Review 1.  Recombinant antibodies aggregation and overcoming strategies in CHO cells.

Authors:  Tingting Xu; Jihong Zhang; Tianyun Wang; Xiaoyin Wang
Journal:  Appl Microbiol Biotechnol       Date:  2022-05-24       Impact factor: 4.813

2.  Increase recombinant antibody yields through optimizing vector design and production process in CHO cells.

Authors:  Yongxiao Yang; Zhengmei Li; Qin Li; Kai Ma; Yan Lin; Huigen Feng; Tianyun Wang
Journal:  Appl Microbiol Biotechnol       Date:  2022-07-05       Impact factor: 5.560

Review 3.  Progress of Transposon Vector System for Production of Recombinant Therapeutic Proteins in Mammalian Cells.

Authors:  Mian Wei; Chun-Liu Mi; Chang-Qin Jing; Tian-Yun Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-05-04

Review 4.  Advances of Glycometabolism Engineering in Chinese Hamster Ovary Cells.

Authors:  Huan-Yu Zhang; Zhen-Lin Fan; Tian-Yun Wang
Journal:  Front Bioeng Biotechnol       Date:  2021-12-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.